Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
Search by tag: horizon
Amgen to buy Horizon Therapeutics in $26.4B deal
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune dis...
TD Bank bids $13B for First Horizon in southeastern US push
Toronto-Dominion Bank is buying regional bank First Horizon in a $13.4 billion all-cash deal that will help broaden its...
Apple shines in pandemic with $2 trillion value on horizon
Early in 2020, Apple appeared to be caught in a horrible bind
Peugeot maker sees record profit, but virus clouds horizon
Peugeot maker PSA Group says it has lost 700 million euros in China despite record profits last year
